OWL THERAPEUTICS
LIVE

Serial Number

98844292

Owner

Owl Therapeutics, LLC

Attorney

Jennifer Sheehan Anderson

Filing Date

Nov 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

OWL THERAPEUTICS Trademark

Serial Number: 98844292

OWL THERAPEUTICS is a trademark filed by Owl Therapeutics, LLC on November 8, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Owl Therapeutics, LLC

200 E Grayson St. Ste 101
San Antonio, TX 78215

Entity Type: 16

Trademark Details

Filing Date

November 8, 2024

Registration Date

Not Registered

Published for Opposition

May 13, 2025

Goods & Services

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2026 EXRA
SOU EXTENSION 2 GRANTED
Jul 8, 2026 EX2G
SOU EXTENSION 2 FILED
Jul 8, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 8, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 31, 2025 EXRA
SOU EXTENSION 1 GRANTED
Jul 30, 2025 EX1G
SOU EXTENSION 1 FILED
Jul 30, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 30, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 8, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 13, 2025 NPUB
PUBLISHED FOR OPPOSITION
May 13, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 7, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 11, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 11, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 11, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 11, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 11, 2025 CNEA
ASSIGNED TO EXAMINER
Apr 9, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2024 NWOS
NEW APPLICATION ENTERED
Nov 8, 2024 NWAP